Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders' Equity

v2.4.0.6
Consolidated Statement of Changes in Stockholders' Equity (USD $)
Total
Common Stock
Additional Paid-in Capital
Deficit Accumulated During the Development Stage
Beginning Balance at Jun. 13, 2000        
Issuance of founder shares $ 30,000 $ 9,990 $ 20,010  
Issuance of founder shares, Shares   999,000    
Proceeds from issuance of - stock 1,750,000 1,457 1,748,543  
Proceeds from issuance of - stock, Shares   145,687    
Net loss (672,286)     (672,286)
Balance at Dec. 31, 2000 1,107,714 11,447 1,768,553 (672,286)
Balance, Shares at Dec. 31, 2000   1,144,687    
Proceeds from issuance of - stock 2,250,000 1,873 2,248,127   
Proceeds from issuance of - stock, Shares   187,313    
Net loss (5,090,621)     (5,090,621)
Balance at Dec. 31, 2001 (1,732,907) 13,320 4,016,680 (5,762,907)
Balance, Shares at Dec. 31, 2001   1,332,000    
Proceeds from issuance of - stock 3,250,000 1,804 3,248,196   
Proceeds from issuance of - stock, Shares   180,375    
Net loss (3,192,384)     (3,192,384)
Balance at Dec. 31, 2002 (1,675,291) 15,124 7,264,876 (8,955,291)
Balance, Shares at Dec. 31, 2002   1,512,375    
Proceeds from issuance of - stock 6,781,250 2,090 6,779,160   
Proceeds from issuance of - stock, Shares   208,992    
Net loss (3,532,044)     (3,532,044)
Balance at Dec. 31, 2003 1,573,915 17,214 14,044,036 (12,487,335)
Balance, Shares at Dec. 31, 2003   1,721,367    
Proceeds from issuance of - stock 4,600,000 7,659 4,592,341   
Proceeds from issuance of - stock, Shares   765,900    
Net loss (5,734,791)       (5,734,791)
Balance at Dec. 31, 2004 439,124 24,873 18,636,377 (18,222,126)
Balance, Shares at Dec. 31, 2004   2,487,267    
Proceeds from issuance of - stock 3,900,000 6,494 3,893,506   
Proceeds from issuance of - stock, Shares   649,350    
Option expense 315,388    315,388   
Net loss (4,580,237)       (4,580,237)
Balance at Dec. 31, 2005 74,275 31,367 22,845,271 (22,802,363)
Balance, Shares at Dec. 31, 2005   3,136,617    
Proceeds from issuance of - stock 7,550,541 8,390 7,542,151   
Proceeds from issuance of - stock, Shares   839,042    
Option expense 252,308    252,308   
Net loss (6,053,362)       (6,053,362)
Balance at Dec. 31, 2006 1,823,762 39,757 30,639,730 (28,855,725)
Balance, Shares at Dec. 31, 2006   3,975,659    
Proceeds from issuance of - stock 6,600,000 7,326 6,592,674   
Proceeds from issuance of - stock, Shares   732,600    
Common stock issued for services 398,810 664 398,146   
Common stock issued for services, Shares   66,402    
Option expense 255,061    255,061   
Net loss (5,617,581)       (5,617,581)
Balance at Dec. 31, 2007 3,460,052 47,747 37,885,611 (34,473,306)
Balance, Shares at Dec. 31, 2007   4,774,661    
Proceeds from issuance of - stock 6,000,000 9,990 5,990,010   
Proceeds from issuance of - stock, Shares   999,000    
Option expense 269,618    269,618   
Net loss (5,570,905)       (5,570,905)
Balance at Dec. 31, 2008 4,158,765 57,737 44,145,239 (40,044,211)
Balance, Shares at Dec. 31, 2008   5,773,661    
Option expense 112,382    112,382   
Net loss (3,425,986)       (3,425,986)
Balance at Dec. 31, 2009 845,161 57,737 44,257,621 (43,470,197)
Balance, Shares at Dec. 31, 2009   5,773,661    
Option expense 21,166    21,166   
Net loss (467,266)       (467,266)
Balance at Dec. 31, 2010 399,061 57,737 44,278,787 (43,937,463)
Balance, Shares at Dec. 31, 2010   5,773,661    
Proceeds from issuance of - stock 5,379,367 78,911 5,300,456   
Proceeds from issuance of - stock, Shares   7,891,141    
Option expense 19,935    19,935   
Warrant expense 2,153,442    2,153,442   
Fair value of derivative warrants (3,887,850)    (3,887,850)   
Beneficial conversion feature discount 372,850    372,850   
Net loss (3,444,795)       (3,444,795)
Balance at Dec. 31, 2011 992,010 136,648 48,237,620 (47,382,258)
Balance, Shares at Dec. 31, 2011   13,664,802    
Proceeds from issuance of - stock 5,129,940 40,877 5,089,063   
Proceeds from issuance of - stock, Shares   4,087,747    
Conversion of notes payable and accrued interest to stock 981,729 12,525 969,204   
Conversion of notes payable and accrued interest to stock, Shares   1,252,550    
Shares issued at the reverse merger    23,866 (23,866)   
Shares issued at the reverse merger, Shares   2,386,566    
Option expense 266,172    266,172   
Warrant expense 1,957,754    1,957,754   
Fair value of derivative warrants (4,052,089)    (4,052,089)   
Transfer from liability classification to equity classification 4,231,324    4,231,324   
Net loss (8,361,205)       (8,361,205)
Balance at Dec. 31, 2012 $ (1,145,635) $ 213,916 $ 56,675,181 $ (55,713,465)
Balance, Shares at Dec. 31, 2012   21,391,665